| ncRNA name | hsa-miR-26a |
| ncRNA Category | miRNA |
| Disease name | diabetic retinopathy (DR) |
| Species | Homo sapiens |
| Tissues/Cell_line | human RPE ARPE-19 |
| Methods | CCK-8 assay, flow cytometry, DCFH-DA staining, qRT-PCR, Western blot |
| Expression pattern | up-regulated |
| Functional description | Rg1 protected ARPE-19 cells against HG-induced injury through up-regulating miR-26a, along with inhibition of the ERK and Wnt/β-catenin pathways. |
| PubMed ID | 30763577 |
| Year | 2019 |
| Title | Ginsenoside Rg1 protects human retinal pigment epithelial ARPE-19 cells from toxicity of high glucose by up-regulation of miR-26a. |
| Drug-related ncRNA | YES (Ginsenoside Rg1) |
Copyright © Institution of Biomedical Big Data, Wenzhou Medical University All rights reserved.